Toru Imai
Overview
Explore the profile of Toru Imai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuwana T, Kinoshita K, Yamaya Y, Takahashi K, Yamaguchi J, Sakurai A, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518757
: The 28-day mortality rate for septic shock is high, necessitating rapid and effective empiric antimicrobial therapy. In this study, we investigate whether the rate of catecholamine dose reduction in...
2.
Imai T, Shoji H, Hirano H, Matsuguma K, Awatsu T, Hirose T, et al.
CNS Oncol
. 2024 Jun;
13(1):2347824.
PMID: 38869444
This report describes a case of BRAF V600E-mutated colorectal cancer with CNS metastases in which treatment with encorafenib, binimetinib and cetuximab was effective. There is limited information on the ability...
3.
Imai T, Kojima Y, Shimoi T, Aiba H, Okuma H, Saito A, et al.
Anticancer Res
. 2024 Apr;
44(5):2125-2132.
PMID: 38677749
Background/aim: Trabectedin is used as a treatment for advanced-stage soft tissue sarcomas (STSs), particularly liposarcoma and leiomyosarcoma. Aside from its direct effect on tumor cells, trabectedin can affect the immune...
4.
Kuwana T, Kinoshita K, Mizuochi M, Sato J, Chiba N, Saito T, et al.
J Pers Med
. 2024 Mar;
14(3).
PMID: 38540984
Dextromethorphan (DXM) is used to treat colds and coughs; however, it can cause central nervous system symptoms, such as severe serotonin syndrome (SS). To our knowledge, there is no specific...
5.
Aiba H, Kojima Y, Shimoi T, Sudo K, Yazaki S, Imai T, et al.
Cancer Med
. 2024 Mar;
13(5):e7060.
PMID: 38466026
Background: Skeletal-related events (SREs), including the pathological fracture, surgical treatment or radiation of bone lesions, malignant spinal cord compression, hypercalcemia, are important considerations when managing metastatic bone tumors; however, owing...
6.
Hirayama T, Igarashi E, Wada S, Sadahiro R, Oshikiri H, Suzuka M, et al.
Palliat Support Care
. 2024 Feb;
:1-8.
PMID: 38409802
Objectives: There is concern that hydroxyzine exacerbates delirium, but a recent preliminary study suggested that the combination of haloperidol and hydroxyzine was effective against delirium. This study examined whether the...
7.
Imai T, Yoshida T, Ohe Y
Thorac Cancer
. 2024 Feb;
15(9):749-751.
PMID: 38379439
Drug-related pneumonitis (DRP) caused by epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is a fatal adverse event in patients with EGFR-mutant non-small cell lung cancer (NSCLC). The diagnosis of...
8.
Kawamura Y, Nakanishi K, Murata Y, Teranishi K, Miyazaki R, Toda K, et al.
Cytometry A
. 2023 Dec;
105(3):196-202.
PMID: 38087915
Early diagnosis and prompt initiation of appropriate treatment are critical for improving the prognosis of acute leukemia. Acute leukemia is diagnosed by microscopic morphological examination of bone marrow smears and...
9.
Aiba H, Kojima Y, Shimoi T, Sudo K, Yazaki S, Imai T, et al.
Jpn J Clin Oncol
. 2023 Apr;
53(7):604-610.
PMID: 37093679
Objective: Given the rarity of cutaneous/subcutaneous Ewing sarcoma, their clinical characteristics remain poorly understood. In this study, we aimed to analyse the clinical characteristics of patients with cutaneous/subcutaneous Ewing sarcoma...
10.
Uchiike A, Tsurusaki D, Kikuchi N, Imai T, Otsuka S, Motoyoshi K, et al.
Int J Clin Pharmacol Ther
. 2023 Mar;
PMID: 36871245
Objective: Edoxaban is sometimes given at reduced doses when used concomitantly with physical prophylaxis to prevent symptomatic venous thromboembolism (VTE) after total hip arthroplasty (THA). This study aimed to evaluate...